Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Medicine.
Press releases published on September 2, 2025
Tissue Sealants & Adhesives Market to Reach US$ 4.6 Bn by 2035, Expanding at 6.4% CAGR – Analysis by TMR
EIN Presswire
·
September 2, 2025
Tissue Sealants …
Physician Dispensed Cosmeceuticals Market to Hit US$ 44.6 Bn by 2035, Rising at 7.1% CAGR – Growth Insights by TMR
EIN Presswire
·
September 2, 2025
Physician Dispensed Cosmeceuticals Market Size to Grow at 7.1% CAGR, Reaching US$ 44.6 Billion by 2035 – Analysis by Transparency Market Research WILMINGTON, DE, UNITED STATES, September 2, 2025 /EINPresswire.com/ -- The global physician dispensed …
Curium’s bold vision to treat 80% of cancers within 15 years
EIN Presswire
·
September 2, 2025
LONDON, UNITED KINGDOM, September 2, 2025 /EINPresswire.com/ -- In an exclusive interview with The European’s Juliette Foster, Curium Group CEO Renaud Dehareng outlines his plan to treat up to 80% of cancers within the next few decades, explains how …
Qruise and Qblox partner to accelerate scalable quantum computing
EIN Presswire
·
September 2, 2025
Qruise and Qblox unite to deliver seamless software–hardware integration, accelerating scalable, fault-tolerant quantum computing. SAARBRüCKEN, GERMANY, September 2, 2025 /EINPresswire.com/ -- Today, Qruise and Qblox announced a strategic partnership …
Fassadenklar warnt vor Gesundheitsrisiken durch Vogelkot an Fassaden und startet kostenlose Probereinigung
EIN Presswire
·
September 2, 2025
Fassadenklar warnt vor gesundheitlichen Risiken durch Vogelkot an Fassaden und bietet kostenlose Probereinigung zum Schutz von Haus und Bewohnern. STUTTGART, GERMANY, September 2, 2025 /EINPresswire.com/ -- Das Reinigungsunternehmen Fassadenklar weist …
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
September 2, 2025
SAN DIEGO, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1 inhibitor for patients with ovarian cancer and other …
Rapid Micro Biosystems to Present at the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
September 2, 2025
LEXINGTON, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and …
Flex Raises $15M to Unlock $150B in Untapped Pre-Tax Spending for Leading Health & Wellness Retailers
GlobeNewswire
·
September 2, 2025
SAN FRANCISCO, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Flex, the leading platform that enables health and wellness brands to accept Health Savings Account (HSA) and Flexible Spending Account (FSA) payments, has raised $15 million in Series A funding, bringing …
Vaxart Announces Retirement of Chairman Michael J. Finney, Ph.D. from the Board of Directors
GlobeNewswire
·
September 2, 2025
SOUTH SAN FRANCISCO, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT) (“Vaxart” or the “Company”), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its proprietary delivery platform, …
Korro to Participate in Upcoming Investor and Scientific Conferences
GlobeNewswire
·
September 2, 2025
CAMBRIDGE, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO) today announced that members of management will participate in the following upcoming investor and scientific conferences for the month of September: Citi's 2025 …
Therapeutic potential for PEPITEM in osteoporosis
EIN Presswire
·
September 2, 2025
New study shows PEPITEM reduces bone resorption, increases bone formation, and promotes the growth of capillaries from pre-existing blood vessels in bone BIRMINGHAM, WEST MIDLANDS, UNITED KINGDOM, September 2, 2025 /EINPresswire.com/ -- Birmingham …
Teva to Present at Morgan Stanley Global Healthcare Conference and Bank of America Global Healthcare Conference in September
GlobeNewswire
·
September 2, 2025
TEL AVIV, Israel, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, will present at two upcoming investor conferences in September as follows: Morgan …
Nyxoah Announces Upcoming Investor Events
GlobeNewswire
·
September 2, 2025
Nyxoah Announces Upcoming Investor Events Mont-Saint-Guibert, Belgium – September 2, 2025, 10:30pm CET / 4:30PM ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company that develops breakthrough treatment …
Nyxoah Annonce ses Prochains Événements Destinés aux Investisseurs
GlobeNewswire
·
September 2, 2025
Nyxoah Annonce ses Prochains Événements Destinés aux Investisseurs Mont-Saint-Guibert, Belgique – 2 septembre 2025, 22h30 CET / 16h30 ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (« Nyxoah » ou la « Société »), une société de technologie médicale …
Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
September 2, 2025
BOSTON, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. (Nasdaq: TRDA) today announced that the Company granted an aggregate of 54,360 restricted stock units (“RSUs”) and options to purchase 38,850 shares of the Company’s common stock to …
Sanara MedTech Inc. Announces Chief Executive Officer Transition
GlobeNewswire
·
September 2, 2025
Seth Yon Appointed President, Chief Executive Officer and Director; Ron Nixon to Remain Executive Chairman FORT WORTH, TX, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical …
MacroGenics to Present at H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
September 2, 2025
ROCKVILLE, MD, Sept. 02, 2025 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing innovative antibody-based therapeutics for the treatment of cancer, today announced that MacroGenics’ President …
Plus Therapeutics to Participate in Fireside Chat at the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
September 2, 2025
HOUSTON, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) …
Nanobiotix to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
September 2, 2025
PARIS and CAMBRIDGE, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘Company’’), a late-clinical stage biotechnology company pioneering nanoparticle-based approaches to expand treatment possibilities for …
Nanobiotix participera à la conférence investisseurs annuelle H.C. Wainwright global investment
GlobeNewswire
·
September 2, 2025
PARIS et CAMBRIDGE, Mass., 02 sept. 2025 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext : NANO –– NASDAQ : NBTX – la « Société »), société française de biotechnologie en phase de développement clinique avancé, pionnière des approches fondées sur les …